Cardiol Therapeutics Inc. (CRDL)

0.95

-0.04 (-4.39%)

At close: Mar 28, 2025, 3:59 PM

0.95

0.10%

After-hours: Mar 28, 2025, 07:56 PM EDT

Cardiol Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-28.13K	-30.93M	-31.64M	-20.64M	-13.68M	-15.89M	-1.66M
Depreciation & Amortization	248.35	219.91K	220.42K	229.54K	150.57K	91.49K	53.34K
Stock-Based Compensation	4.17M	5.01M	8.5M	2.77M	3.27M	1.65M	237.27
Other Working Capital	679.62	5.89M	-2.27M	7.22M	-1.76M	-7.17M	-128.33K
Other Non-Cash Items	-4.17M	1.89M	4.21M	144.99K	507.74K	574.86K	267.01K
Deferred Income Tax	n/a	-9.16M	-4.92M	n/a	n/a	7.88M	n/a
Change in Working Capital	746.80	5.75M	76.52K	8.32M	-1.62M	-5.2M	48.38K
Operating Cash Flow	-25.18K	-27.22M	-23.55M	-9.19M	-11.38M	-10.89M	-1.29M
Capital Expenditures	-64.31	-74.71K	-12.92K	-40.6K	-424.31K	-13.79K	-29.17K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	-7.23K
Investing Cash Flow	-64.31	-74.71K	-12.92K	-40.6K	-424.31K	-13.79K	-29.17K
Debt Repayment	-55.38K	-53.93K	-51.92K	-50.47K	-20.19K	12.07M	400K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	55.32K	-0.00	9.41M	-904.51K	382.15K	-1.02M	-120.55K
Financial Cash Flow	-55.38	-53.93K	93.44M	16.3M	2.03M	25.28M	3.68M
Net Cash Flow	-24.54K	-24.43M	69.87M	7.07M	-9.78M	14.37M	2.36M
Free Cash Flow	-25.24K	-27.3M	-23.56M	-9.23M	-11.8M	-10.91M	-1.32M